Thursday, September 19, 2024
HomeTagsAffyImmune

AffyImmune

AffyImmune Appoints Dr. Daniel Janse as Chief Executive Officer

AffyImmune, a clinical-stage biotechnology company committed to developing novel, first-in-class CAR T cell therapies, announced the appointment of Daniel Janse, Ph.D. as President and...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics